Evaluate Study Conduct
Assess protocol adherence, study execution, observations, raw data, specimen handling and reporting to determine whether study evidence is complete and reliable.
Independent, risk-based GLP audits for nonclinical laboratories, contract research organizations, test facilities and regulated research environments seeking stronger study integrity, reliable raw data, effective quality assurance and inspection-ready operations.
GLP audits evaluate whether studies are planned, conducted, monitored, recorded, reported and archived in a controlled manner that supports scientific integrity, regulatory confidence and reliable reconstruction.
Assess protocol adherence, study execution, observations, raw data, specimen handling and reporting to determine whether study evidence is complete and reliable.
Review facilities, equipment, computerized systems, methods, environmental conditions and operational controls supporting regulated nonclinical work.
Evaluate the independence, planning, execution, reporting and follow-up activities of the quality assurance unit.
GLP risk often emerges where raw data cannot be reconstructed, responsibilities are unclear, equipment control is weak or quality assurance activities do not identify systemic issues.
Observations, calculations, corrections, metadata or source records do not provide a complete and attributable reconstruction of study work.
Study activities, methods or laboratory processes are not performed consistently with approved protocols and controlled procedures.
Qualification, calibration, maintenance, access control or audit trail practices do not adequately support data reliability.
QA inspections, findings, escalation or follow-up activities do not provide sufficient independent assurance over study and facility risk.
Audit scope can focus on a single study, facility, method, system or process, or support a wider GLP compliance and inspection-readiness program.
Independent review of the overall GLP framework, organizational controls, facilities, equipment, systems, documentation and QA oversight.
Assessment of study execution from protocol approval through raw data, observations, analysis, reporting and archival.
Focused review of high-risk laboratory and study-support processes where control weaknesses may affect study reliability.
Evaluation of electronic records, system lifecycle controls, access, audit trails and data integrity risks within GLP operations.
Independent assessment of QA independence, inspection planning, reporting, escalation and follow-up effectiveness.
Focused independent review when data reliability, repeat deviations, study conduct or potential systemic failures require urgent assessment.
The final audit scope is adapted to the study type, facility, computerized environment, known risks and intended regulatory or business outcome.
The process is designed to produce objective findings, clear risk classification and practical recommendations for laboratory, QA and leadership teams.
Understand the facility, study type, systems, previous findings, inspection exposure and business purpose of the audit.
Define audit criteria, documentation needs, sampling strategy, interviewees and high-risk areas requiring deeper review.
Review protocols, SOPs, study records, QA documentation, equipment records, validation files and available quality data.
Conduct interviews, laboratory walkthroughs, study reconstruction, document review, raw data sampling and system demonstrations.
Assess significance, recurrence, systemic impact and potential effect on study integrity or regulatory confidence.
Deliver risk-ranked findings, recommendations and optional CAPA review or effectiveness verification support.
Deliverables can be adapted to qualification, routine compliance, inspection readiness, due diligence or for-cause audit objectives.
GLP audits can support qualification, routine assurance, inspection preparation, transaction due diligence or urgent independent review.
A laboratory or CRO requires independent assessment before study award or contract renewal.
The organization needs assurance over study, facility, QA and data readiness before regulatory scrutiny.
Raw data, protocol compliance or study reconstruction requires focused independent review.
Similar findings or deviations indicate a possible systemic laboratory or quality-system weakness.
Electronic records, audit trails or system lifecycle controls require independent assessment.
Leadership needs an independent view of QA coverage, independence and inspection effectiveness.
A laboratory, research platform or acquisition target requires GLP compliance and quality-risk assessment.
Serious study or data concerns require confidential and targeted independent assurance.
Independent GLP audits help organizations identify weaknesses earlier, strengthen laboratory governance and improve confidence in study data, facility control and quality assurance.
Improve confidence that raw data, observations, calculations and final reports are complete, traceable and reconstructable.
Identify weaknesses in equipment, systems, methods, environmental conditions and operational governance.
Strengthen QA independence, inspection coverage, escalation and follow-up across studies and laboratory processes.
Common questions from laboratories, CROs, sponsors and research organizations considering independent GLP audit support.
Yes. Depending on the scope, document availability and system access, selected facility, study, process and computerized system audits can be delivered remotely or through a hybrid model.
Yes. A study audit can focus on protocol compliance, raw data, specimen control, equipment, computerized systems, reporting and study reconstruction.
Yes. Qualification, requalification and oversight audits can be performed for contract research organizations, laboratories and other regulated service providers.
Yes. Scope can include system lifecycle governance, validation, access control, audit trails, electronic records, backup, retention and data integrity.
Yes. Support can include root cause review, CAPA adequacy assessment, remediation planning and follow-up effectiveness verification.
Yes. GLP audit engagements are handled confidentially, and NDA-based collaboration can be used where required.